Ferozsons Laboratories Limited
Condensed Interim Unconsolidated Statement of Profit or Loss (Un-audited)
For the nine months and quarter ended 31 March 2024
Nine months ended | Q uarter ended | ||||||
31 March | 31 March | 31 March | 31 March | ||||
2024 | 2023 | 2024 | 2023 | ||||
------------------ Rupees ------------------ | ------------------ Rupees ----------------- | ||||||
Revenue - net | 9,559,152,966 | 7,294,218,488 | 2,848,274,988 | 2,688,405,466 | |||
Cost of sales | (5,925,354,117) | (4,225,496,463) | (1,704,606,460) | (1,563,072,769) | |||
Gross profit | 3,633,798,849 | 3,068,722,025 | 1,143,668,528 | 1,125,332,697 | |||
Administrative expenses | (575,357,917) | (472,798,999) | (215,826,134) | (156,509,258) | |||
Selling and distribution expenses | (2,327,675,346) | (1,797,221,041) | (775,755,858) | (558,105,253) | |||
Other expenses | (138,711,540) | (490,698,057) | (2,150,156) | (328,481,060) | |||
Other income | 156,363,136 | 132,625,801 | 39,752,783 | 40,873,281 | |||
Profit from operations | 748,417,182 | 440,629,729 | 189,689,163 | 123,110,407 | |||
Finance cost | (345,139,267) | (86,795,679) | (164,382,354) | (36,438,807) | |||
Profit before taxation | 403,277,915 | 353,834,050 | 25,306,809 | 86,671,600 | |||
Taxation | (132,905,308) | (130,257,764) | (11,987,745) | (62,234,730) | |||
Profit after taxation | 270,372,607 | 223,576,286 | 13,319,064 | 24,436,870 | |||
Earnings per share - basic and diluted | 6.22 | 5.14 | 0.31 | 0.56 | |||
Ferozsons Laboratories Limited
Condensed Interim Consolidated Statement of Profit or Loss (Un-audited)
For the nine months and quarter ended 31 March 2024
Nine months ended | Quarter ended | ||||||
31 March | 31 March | 31 March | 31 March | ||||
2024 | 2023 | 2024 | 2023 | ||||
-------------- Rupees --------------------------- | -------------- Rupees --------------------------- | ||||||
Revenue - net | 12,042,857,629 | 8,364,397,360 | 3,744,040,006 | 3,124,562,302 | |||
Cost of sales | (7,176,952,583) | (5,009,084,925) | (2,072,410,893) | (1,882,622,972) | |||
Gross profit | 4,865,905,046 | 3,355,312,435 | 1,671,629,113 | 1,241,939,330 | |||
Administrative expenses | (629,952,058) | (516,017,920) | (245,201,131) | (169,680,531) | |||
Selling and distribution expenses | (2,911,232,106) | (1,909,573,523) | (994,165,517) | (602,974,868) | |||
Other expenses | (182,216,664) | (513,181,765) | (7,747,231) | (348,284,971) | |||
Other income | 182,047,772 | 191,470,932 | 39,347,241 | 54,139,561 | |||
Profit from operations | 1,324,551,990 | 608,010,159 | 463,862,475 | 175,138,521 | |||
Finance cost | (451,787,271) | (168,833,739) | (195,755,541) | (75,215,825) | |||
Profit before taxation | 872,764,719 | 439,176,420 | 268,106,934 | 99,922,696 | |||
Taxation | (314,296,863) | (147,608,315) | (102,738,179) | (59,974,602) | |||
Profit after taxation | 558,467,856 | 291,568,105 | 165,368,755 | 39,948,094 | |||
Attributable to: | |||||||
Owners of the Group | 499,816,003 | 277,218,081 | 134,826,782 | 36,307,529 | |||
Non-controlling interests | 58,651,853 | 14,350,024 | 30,541,973 | 3,640,565 | |||
Profit after taxation | 558,467,856 | 291,568,105 | 165,368,755 | 39,948,094 | |||
Earnings per share - basic and diluted | 11.50 | 6.38 | 3.10 | 0.84 | |||